References of "Melin, Pierrette"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailDetection of Aspergillus spp. by PCR in Bronchoalveolar Lavage Fluid
Hayette, Marie-Pierre ULg; Vaira, Dolorès ULg; Suzin, Fabrice et al

in Journal of Clinical Microbiology (2001), 39(6), 2338-2340

The usefulness of a nested PCR assay for detection of Aspergillus sp. DNA was evaluated in 177 bronchoalveolar lavage (BAL) fluid specimens. This test was accurate both to diagnose culture-negative BAL ... [more ▼]

The usefulness of a nested PCR assay for detection of Aspergillus sp. DNA was evaluated in 177 bronchoalveolar lavage (BAL) fluid specimens. This test was accurate both to diagnose culture-negative BAL fluid specimens from patients with invasive pulmonary aspergillosis and to confirm culture-positive samples. However, it did not differentiate between infection and colonization. [less ▲]

Detailed reference viewed: 25 (7 ULg)
See detailIntérêt et techniques de dépistages des infections virales
Melin, Pierrette ULg

Scientific conference (2001, March 19)

Detailed reference viewed: 5 (1 ULg)
Peer Reviewed
See detailPrevention of neonatal group B streptococcal disease in Belgium: hospital policy, obstetricians' practice and laboratory processing
MELIN, Pierrette ULg; Schmitz, Myriam; Heinrichs, I. et al

Poster (2000, November 25)

Detailed reference viewed: 7 (0 ULg)
Peer Reviewed
See detailAntimicrobial Susceptibility of Streptococcus agalactiae Isolated from Patients in Belgium Through 1989-1991 and 1996-1999
MELIN, Pierrette ULg; Rodriguez Cuns, Grisel; Vincento Fernandez, Walter et al

in Martin, Diana R.; Tagg, John R. (Eds.) Streptococci and Streptococcal Diseases Entering the New Millenium - Proceeding of the XIV LISSSD (2000, November)

Detailed reference viewed: 3 (0 ULg)
See detailSerotype Distribution of Invasive Streptococcus agalactiae Isolated from Neonates and Adults in Belgium over a 4-years Period (1995-1999)
Melin, Pierrette ULg; De Mol, Patrick ULg

in Martin, Diana R; Tagg, John R (Eds.) Streptococci and Streptococcal Diseases - Entering the New Millenium", Proceedings of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases (2000)

Detailed reference viewed: 12 (0 ULg)
See detailAntimicrobial Susceptibility of Streptococcus agalactiae Isolated from Patients in Belgium through 1989-1991 and 1996-1999
Melin, Pierrette ULg; Rodriguez Cuns, Grisel; Vicentino Fernandez, Walter et al

in Martin, Diana R; Tagg, John R (Eds.) Streptococci and Streptococcal Diseases - Entering the New Millenium", Proceedings of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases (2000)

Detailed reference viewed: 8 (0 ULg)
Peer Reviewed
See detailSerotype distribution of invasive Streptococcus agalactiae isolated from neonates and adults in Belgium over a 4-year period (1995-1999)
MELIN, Pierrette ULg; De Mol, Patrick ULg

in Martin, Diana R.; Tagg, John R. (Eds.) Streptococci and Streptococcal Diseases Entering the New Millenium - Proceeding of the XIV LISSSD (2000, November)

Detailed reference viewed: 4 (0 ULg)
See detailStrep B OIA and prenatal cultures for identification of GBS carriers at delivery
Melin, Pierrette ULg

Conference (2000, October 31)

Detailed reference viewed: 5 (0 ULg)
See detailPrévention des infections périnatales à streptocoques du groupe B.
Melin, Pierrette ULg

Scientific conference (2000, October 05)

Detailed reference viewed: 5 (1 ULg)
Peer Reviewed
See detailPrevention of neonatal group B streptococcal disease in Belgium: hospital policy, obstetricians' practice and laboratory processing
MELIN, Pierrette ULg; Schmitz, Myriam; Heinrichs, I. et al

in American Society of Microbiology (Ed.) Program and Abstracts of the 40th Intersciences Conference on Antimicrobial Agents and Chemotherapy (2000, September)

Detailed reference viewed: 20 (5 ULg)
Full Text
Peer Reviewed
See detailRapid intrapartum test (Strep B OIA) and prenatal cultures for identification of group B streptococcal carriers at delivery: a prospective study
MELIN, Pierrette ULg; Schmitz, Myriam; Tsobo, Chantal et al

in AAmerican Society of Microbiology (Ed.) Program and Abstracts of the 40th Intersciences Conference on Antimicrobial Agents and Chemotherapy (2000, September)

Background: The efficacy of the prenatal screening-based approach recommended by the CDC to prevent neonatal GBS diseases could be improved by using a good rapid test performed at the onset of labor. To ... [more ▼]

Background: The efficacy of the prenatal screening-based approach recommended by the CDC to prevent neonatal GBS diseases could be improved by using a good rapid test performed at the onset of labor. To assess the Strep B OIA® test (Biostar, Boulder, Co), completed in 30 minutes, we initiated a 6-center study to compare it with prenatal screening cultures to identify GBS carriers at delivery or opportunities to initiate intrapartum antibioprophylaxis (IAP). Methods: For a total of 539 pregnant women included in the study, pairs of vaginal/anal specimens collected at 35-37 weeks and intrapartum vaginal specimens were plated onto colistin-nalidixic agar and then inoculated into selective LIM broth for the detection of GBS. Furthermore, on each intrapartum vaginal swab a Strep B OIA test was performed. Results: GBS were recovered in culture from 89 prenatal screenings (17%) and from 71 specimens collected at delivery (13%). Strep B OIA test identified 48 positive specimens (9%). Respectively, for the identification of GBS carriers at delivery, sensitivity, specificity, positive and negative predictive values for prenatal screening cultures were 69%, 91%, 55% and 95% and for Strep B OIA tests they were 63%, 99%, 94% and 95%. Evaluating opportunities to start an IAP, based on Strep OIA test versus prenatal screening cultures, 45 IAP vs. 49 would have been useful, 3 vs. 40 useless (P< 0,001) and 26 vs. 22 missed. Conclusion: To identify GBS carriers, the Strep B OIA test, performed at the time of onset of labor is equally sensitive to prenatal screening cultures and would allow a highly significant reduction of useless IAP. [less ▲]

Detailed reference viewed: 43 (0 ULg)